They act differently and should not be treated as substitutes
Dermal fillers and botulinum toxin products may appear in the same aesthetic conversation, but they are different product classes with different actions. In the United States, the FDA describes dermal fillers as medical device implants used to create a smoother or fuller appearance in selected areas, while approved botulinum toxin products are prescription drugs that temporarily reduce activity in targeted muscles or glands. A brand name, an injection site or a social-media result does not establish which option is appropriate. The useful starting point is the concern being assessed, the anatomy involved, the exact product and its authorised use in the relevant jurisdiction.
Verify the exact product, source and practitioner
Ask for the full product name, manufacturer, batch or lot details where available, packaging and the indication being proposed. The FDA's dermal-filler guidance, updated 14 February 2025, advises patients to use a licensed healthcare professional experienced in anatomy and complication management, and to confirm that the filler is in unopened, properly labelled packaging. It also warns against self-injection, products sold directly to the public and needle-free filler devices. For botulinum toxin, a 5 November 2025 FDA enforcement notice reported warning letters concerning illegally marketed unapproved or misbranded products sold online. That action is specific to the United States, but the broader verification questions travel well: who supplied the product, is it authorised for this use locally, and is the practitioner appropriately qualified?
Different risks require different emergency plans
Filler complications can include infection, nodules and tissue injury. Accidental injection into a blood vessel is uncommon but can cause tissue death, stroke or blindness; unusual pain, skin whitening or discolouration, vision change or stroke-like symptoms after treatment require immediate emergency assessment. Botulinum toxin products carry different risks, including unwanted weakness and, rarely, effects consistent with spread of toxin. Difficulty swallowing or breathing, or marked muscle weakness, warrants urgent medical care. These examples are not a complete risk list, and an FDA-authorised product does not guarantee a safe or satisfactory individual outcome.
Use a consultation to compare goals, evidence and safeguards
A responsible discussion should connect the proposed product to a defined goal, explain alternatives including no treatment, disclose the practitioner's training and experience, and set out aftercare and a reachable complication pathway. Ask whether the proposed site and use appear on the local product information and what evidence supports any off-label proposal. If filler and botulinum toxin are suggested together, request a separate rationale and consent discussion for each; the FDA notes that combining dermal fillers with products such as Botox has not been evaluated in clinical studies. This article does not establish Hong Kong approval status, personal suitability or whether A New You supplies either treatment.
Common questions
Are filler and botulinum toxin the same treatment?
No. Fillers are implantable materials intended to add or restore volume in selected areas, while botulinum toxin products are prescription drugs that temporarily reduce activity in targeted muscles or glands. Exact products, authorised uses and rules vary by jurisdiction.
Does FDA authorisation guarantee that an injection is safe?
No. Authorisation applies to a specific product and use in a specific jurisdiction. Technique, anatomy, practitioner competence, patient factors and complication response still matter, and no procedure is risk-free.
Can filler and botulinum toxin be used in the same visit?
A qualified clinician must assess this individually. Ask for a separate rationale, product check, consent and complication plan for each procedure. The FDA says the safety of combining dermal fillers with products such as Botox has not been evaluated in clinical studies.
Which symptoms need urgent medical attention?
After filler, unusual pain, skin whitening or discolouration, vision change or stroke-like symptoms need immediate emergency assessment. After botulinum toxin, difficulty swallowing or breathing, or marked muscle weakness, warrants urgent care.
Sources
- US FDA — Dermal Filler Do's and Don'ts for Wrinkles, Lips and More (updated 14 February 2025) ↗
- US FDA — FDA Warns Companies Over Illegal Marketing of Botox and Related Products (5 November 2025) ↗
Educational information only, not diagnosis, prescribing or personalised medical advice. Product classifications, authorised uses and practitioner rules differ by jurisdiction; the FDA examples here describe the United States and do not establish Hong Kong status. Seek an appropriately qualified local healthcare professional and emergency services for urgent symptoms.
This guide was written and edited by the A New You editorial team and has not been medically reviewed. It is not personal diagnosis or medical advice. Suitability for any treatment requires an individual assessment; seek qualified medical care for persistent or concerning symptoms.